Uses of the peptide of sequence His-D-Trp-Ala-Trp-d-Phe-Lys-NH2 for reducing or delaying the appearance of cell senescence and signs of skin aging
The present invention relates to the cosmetic use of a composition including, as the active agent, 0.1 to 1 μM of a synthetic peptide of sequence His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 or one of the salts thereof in a physiologically suitable medium, in order to reduce or delay the appearance of cell senescence and signs of skin aging. The present invention also relates to a method for cosmetic treatment which relates to these novel uses, including comprising the steps of applying the composition, topically, at least once per day, for a period of at least two days.
1. A method for increasing the activity of prolidase and the synthesis of collagen in skin, the method comprising topically applying a composition comprising, as the only active agent, between 0.1 and 1 μM of a synthetic peptide with sequence His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 (SEQ ID NO: 1) or one of its salts in a physiologically acceptable medium, wherein the composition is applied topically, at least once per day, for a period of at least 2 days.
2. The method of claim 1 , wherein the composition comprises between 0.5 and 1 μM of said synthetic peptide.
3. The method of claim 1 , wherein the composition comprises less than 1 μM of said synthetic peptide.
4. The method of claim 1 , wherein the composition is applied 2 times per day.
5. The method of claim 1 , wherein the composition is applied over a period of at least 6 weeks.
6. The method of claim 1 , wherein the composition is applied over a period of at least 3 months.
7. A cosmetic treatment method for reducing or delaying the appearance of cellular senescence and the signs of skin aging, the method comprising the topical application, at least once per day over a period of at least 2 days, of a composition comprising, as the only active agent, between 0.1 and 1 μM of a synthetic peptide with the sequence His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 (SEQ ID NO: 1) in a physiologically acceptable medium, where the composition increases the activity of prolidase and the synthesis of collagen.
8. The method of claim 1 , wherein the method reduces or delays the appearance of cellular senescence and signs of skin aging selected from thinning of the skin, sagging, toss of moisture, skin atony, deep wrinkles and fine lines, loss of firmness and tone, dermal atrophy with the exception of pigmentary anomalies of the skin.
9. The method of claim 8 , wherein the signs of skin aging are wrinkles.